LONDON (Reuters) - Shares in AstraZeneca, Europe’s third-biggest drugmaker, jumped on Tuesday on speculation the pharmaceutical group is a takeover target for Swiss rival Novartis but dealers were sceptical of the talk.
LONDON (Reuters) - Shares in AstraZeneca, Europe’s third-biggest drugmaker, jumped on Tuesday on speculation the pharmaceutical group is a takeover target for Swiss rival Novartis but dealers were sceptical of the talk.
